December 11, 2025 17:00 Regulatory Flerie receives FDI-approval for the merger with Lipum Read news release
December 10, 2025 08:00 Non Regulatory Flerie’s portfolio company AnaCardio reports strong Phase 2a data for AC01 in patients with heart failure Read news release
November 4, 2025 Flerie’s portfolio company Empros Pharma reports study results positioning EMP16 as a promising oral weight-loss maintenance therapy Read news release
October 8, 2025 Flerie’s portfolio company Xspray Pharma provides update on FDA process for Dasynoc®; observations at contract manufacturer delay approval Read news release
September 23, 2025 Flerie’s portfolio company Xintela has presented positive 24-month data for its stem cell product XSTEM Read news release